BROSSARD, QUEBEC, CANADA--(Marketwire - Feb. 1, 2011) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge-extraction techniques, announces that Mr. Anthony Siregar is now the Corporation new Vice-President, Business Development for CARA in the Gulf region and Asia-Pacific. Prior to accepting this new role, Mr Siregar was the President of Genesis Knowledge Streams Inc.

Anthony has held several c-level positions in large US and European multinationals, including AT&T, NCR Corp, KNIG, with international field assignments in the US, Europe, Asia Pacific and South America. His industry background includes aerospace, defence, telecom operators, banking, retail, and Not-For-Profit global organizations such as the UN and the World Bank. He holds a Masters degree in computer sciences from the Scientific University of Grenoble, and a post graduate certificate from New York University.

"We are pleased to have Anthony join the firm. The business opportunities in the Gulf Region and Asia are important for our growth. It is anticipated that the cost of diabetes in the Gulf Region will reach $60 Billion over the next 5 years. The same situation is happening in China were the number of Diabetics will reach 500 million people by 2030, as reported in the New England Medical journal this year. Our global market penetration strategy is to address countries with a high diabetes rate, and the countries located in the Gulf region and Asia-Pacific show high prevalence of this decease. Due the high potential of these markets for the commercialization of CARA, we felt the need to have a full-time dedicated person with extensive knowledge of the culture and regulations governing the countries of these regions. Mr Siregar's extensive experience in helping companies develop new business opportunities abroad will be greatly beneficial for DIAGNOS" said André Larente, President and CEO of DIAGNOS.

The CARA suite of applications allows the different players in the diabetic retinopathy screening process to make better informed decisions and extend cost-effective care to a larger patient population.

About CARA

CARA is a tele-ophthalmology platform that integrates with existing equipment (hardware and software) and processes at the point of care (POC) and comprises: image upload, image enhancement automated pre-screening, grading by a specialist, and referral to a specialist. CARA's image enhancement algorithms make standard retinal images sharper, clearer, and easier to read. CARA is accessible securely over the internet, and is compatible with all recognized image formats and brands of fundus cameras. CARA is a cost-effective tool for processing large numbers of images, in real-time and has been issued a licence by Health Canada for commercialization in Canada.


Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including natural resources, healthcare, and entertainment.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.

For further information, please visit our website at or the SEDAR website at

Contact Information: DIAGNOS Inc.
Andre Larente
President and CEO
1-877-678-8882 or 450-678-8882, ext.: 224